Evidence map›Paper›PMID 31191820›Full record

ArticleOncotarget2019

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes.

Faruck L Hakkim, Hamid A Bakshi, Shabia Khan, Mohamad Nasef, Rabia Farzand, Smitha Sam, Luay Rashan, Mohammed S Al-Baloshi, Sidgi Syed Anwar Abdo Hasson, Ali Al Jabri and 2 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2025
    Article
  7. Review
  8. Hydroxypropyl Cellulose Hydrogel ContainingGels (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human Lung Cancer (A549) Cell Line Cytotoxicity and Anti-Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Faruck L HakkimFrankincense Biodiversity Unit, Research Center, Dhofar University, Salalah, Oman.
Hamid A BakshiDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, United Kingdom.
Shabia KhanDepartment of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
Mohamad NasefDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, United Kingdom.
Rabia FarzandDepartment of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hertfordshire, United Kingdom.
Smitha SamChemotherapy Unit, St. Jude Clinics-Center for Cancer Treatment, Pathanamthitta, Kerala, India.
Luay RashanFrankincense Biodiversity Unit, Research Center, Dhofar University, Salalah, Oman.
Mohammed S Al-BaloshiDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Muscat, Oman.
Sidgi Syed Anwar Abdo HassonDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Muscat, Oman.
Ali Al JabriDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Muscat, Oman.
Paul A McCarronSchool of Pharmacy and Pharmaceutical Science, SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, County Londonderry, Northern Ireland, United Kingdom.
Murtaza M TambuwalaSchool of Pharmacy and Pharmaceutical Science, SAAD Centre for Pharmacy and Diabetes, Ulster University, Coleraine, County Londonderry, Northern Ireland, United Kingdom.
Sultan Qaboos University · OMUniversity of Ulster · GBDhofar University · OMLouisiana State University · USUniversity of Hertfordshire · GBUniversity of Huddersfield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is a deadly form of malignancy and according to the World Health Organization 132,000 new cases of melanoma are diagnosed worldwide each year. Surgical resection and chemo/drug treatments opted for early and late stage of melanoma respectively, however detrimental post surgical and chemotherapy consequences are inevitable. Noticeably melanoma drug treatments are associated with liver injuries such as hepatitis and cholestasis which are very common. Alleviation of these clinical manifestations with better treatment options would enhance prognosis status and patients survival. Natural products which induce cytotoxicity with minimum side effects are of interest to achieve high therapeutic efficiency. In this study we investigated anti-melanoma and hepatoprotective activities of frankincense essential oil (FEO) in both

Indexed as

apoptosisessential oilfrankincensemelanomatumor remission

Identifiers

PMID31191820
PMCPMC6544398
OpenAlexW2947302571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.